Epidemiology of doublet/multiplet mutations in lung cancers: evidence that a subset arises by chronocoordinate events
- PMID: 19005564
- PMCID: PMC2579325
- DOI: 10.1371/journal.pone.0003714
Epidemiology of doublet/multiplet mutations in lung cancers: evidence that a subset arises by chronocoordinate events
Abstract
Background: Evidence strongly suggests that spontaneous doublet mutations in normal mouse tissues generally arise from chronocoordinate events. These chronocoordinate mutations sometimes reflect "mutation showers", which are multiple chronocoordinate mutations spanning many kilobases. However, little is known about mutagenesis of doublet and multiplet mutations (domuplets) in human cancer. Lung cancer accounts for about 25% of all cancer deaths. Herein, we analyze the epidemiology of domuplets in the EGFR and TP53 genes in lung cancer. The EGFR gene is an oncogene in which doublets are generally driver plus driver mutations, while the TP53 gene is a tumor suppressor gene with a more typical situation in which doublets derive from a driver and passenger mutation.
Methodology/principal findings: EGFR mutations identified by sequencing were collected from 66 published papers and our updated EGFR mutation database (www.egfr.org). TP53 mutations were collected from IARC version 12 (www-p53.iarc.fr). For EGFR and TP53 doublets, no clearly significant differences in race, ethnicity, gender and smoking status were observed. Doublets in the EGFR and TP53 genes in human lung cancer are elevated about eight- and three-fold, respectively, relative to spontaneous doublets in mouse (6% and 2.3% versus 0.7%).
Conclusions/significance: Although no one characteristic is definitive, the aggregate properties of doublet and multiplet mutations in lung cancer are consistent with a subset derived from chronocoordinate events in the EGFR gene: i) the eight frameshift doublets (present in 0.5% of all patients with EGFR mutations) are clustered and produce a net in-frame change; ii) about 32% of doublets are very closely spaced (< or =30 nt); and iii) multiplets contain two or more closely spaced mutations. TP53 mutations in lung cancer are very closely spaced (< or =30 nt) in 33% of doublets, and multiplets generally contain two or more very closely spaced mutations. Work in model systems is necessary to confirm the significance of chronocoordinate events in lung and other cancers.
Conflict of interest statement
Similar articles
-
Spontaneous multiple mutations show both proximal spacing consistent with chronocoordinate events and alterations with p53-deficiency.Mutat Res. 2004 Oct 4;554(1-2):223-40. doi: 10.1016/j.mrfmmm.2004.05.005. Mutat Res. 2004. PMID: 15450421
-
EGFR somatic doublets in lung cancer are frequent and generally arise from a pair of driver mutations uncommonly seen as singlet mutations: one-third of doublets occur at five pairs of amino acids.Oncogene. 2008 Jul 17;27(31):4336-43. doi: 10.1038/onc.2008.71. Epub 2008 Mar 31. Oncogene. 2008. PMID: 18372921
-
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.Eur Respir J. 2012 Jul;40(1):177-84. doi: 10.1183/09031936.00097311. Epub 2012 Jan 20. Eur Respir J. 2012. PMID: 22267755
-
[TP53 mutations and molecular epidemiology].Gan To Kagaku Ryoho. 2007 May;34(5):683-9. Gan To Kagaku Ryoho. 2007. PMID: 17496437 Review. Japanese.
-
The TP53 gene, tobacco exposure, and lung cancer.Hum Mutat. 2003 Mar;21(3):229-39. doi: 10.1002/humu.10177. Hum Mutat. 2003. PMID: 12619108 Review.
Cited by
-
Hypermutation in human cancer genomes: footprints and mechanisms.Nat Rev Cancer. 2014 Dec;14(12):786-800. doi: 10.1038/nrc3816. Nat Rev Cancer. 2014. PMID: 25568919 Free PMC article. Review.
-
Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2.Eur J Hum Genet. 2016 Jan;24(1):78-85. doi: 10.1038/ejhg.2015.55. Epub 2015 Mar 18. Eur J Hum Genet. 2016. PMID: 25782668 Free PMC article.
-
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.Oncotarget. 2017 May 16;8(20):32626-32638. doi: 10.18632/oncotarget.15945. Oncotarget. 2017. PMID: 28427238 Free PMC article.
-
Crossing fitness valleys via double substitutions within codons.BMC Biol. 2019 Dec 16;17(1):105. doi: 10.1186/s12915-019-0727-4. BMC Biol. 2019. PMID: 31842858 Free PMC article.
-
Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma.Hum Mutat. 2009 Nov;30(11):1583-90. doi: 10.1002/humu.21112. Hum Mutat. 2009. PMID: 19760750 Free PMC article.
References
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001;1:157–162. - PubMed
-
- Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314:268–274. - PubMed
-
- Bielas JH, Loeb LA. Mutator phenotype in cancer: timing and perspectives. Environ Mol Mutagen. 2005;45:206–213. - PubMed
-
- Loeb LA. A mutator phenotype in cancer. Cancer Res. 2001;61:3230–3239. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous